Children exposed to environmental smoking have a higher antibiotic consumption

Percy Nilsson1, Marie Köhler, Per-Olof Ostergren

  • 1Department of Pediatrics, Malmö University Hospital, Lund University, SE-205 02 Malmö, Sweden. percy.nilsson@med.lu.se

Vaccine
|October 21, 2006
PubMed

Insights

Environmental smoking and daycare attendance are key factors influencing antibiotic prescribing in young children. Reducing exposure may decrease antibiotic use and improve child health outcomes.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Antibiotic prescribing patterns in children are influenced by various factors.
  • Understanding these factors is crucial for combating antibiotic resistance.

Purpose of the Study:

  • To identify key factors associated with antibiotic prescribing in 4-year-old children.
  • To inform public health strategies for optimizing antibiotic use.

Main Methods:

  • Analysis of a questionnaire data from 8700 parents of 4-year-old children in Malmö (1999-2004).
  • Statistical analysis to determine significant risk factors for antibiotic treatment.

Main Results:

  • 51.3% of children received antibiotic treatment.
  • Environmental smoking exposure, daycare attendance, parental employment, and Swedish-born parents were significant risk factors.
  • A notable association was found between environmental smoking and antibiotic prescriptions.

Conclusions:

  • Environmental smoking and daycare are significant predictors of antibiotic prescribing in young children.
  • Targeted information campaigns on smoking cessation could reduce antibiotic use.
  • Interventions may yield broader health benefits for children and parents.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...